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Nikolaus BM Császár and Christoph Schmitz*To the Editor
We read with interest the review article by Dr. C.J. Wang
concerning ‘Extracorporeal shockwave therapy in musculo-
skeletal disorders’ published recently in the Journal of
Orthopaedic Surgery and Research (2012, 7:11). Despite
many interesting approaches, this article unfortunately
ignores some major achievements that have been made
during the last years in extracorporeal shock wave therapy
(ESWT) in musculoskeletal disorders:
 Wang [1] mentioned three main techniques
through which shockwaves are generated: the
electrohydraulic, electromagnetic, and piezoelectric
principles. He contrasted them with ultrasound
waves. Unfortunately, Wang [1] forgot to mention
the fourth technique, the ballistic/radial principle.
Notably, Wang [1] cited two randomized controlled
trials (RCTs) performed with the ballistic/radial
principle: (1) Gerdesmeyer et al.’s study on plantar
fasciopathy [2] and (2) Rompe et al.’s study on
insertional Achilles tendinopathy [3]. The study
by Rompe et al. [3] was explicitly discussed as an
ESWT study by Wang [1]: ‘Rompe et al. compared
25 patients treated by eccentric stretching exercises
with 25 patients treated with repetitive ESWT, and
the results showed that eccentric loading is inferior
to ESWT in the treatment of patients with chronic
recalcitrant Achilles tendinopathy’ (page 5, left
column, lines 10ff in [1]).
 Given the fact that Wang [1] cited two RCTs
performed with the ballistic/radial principle [2,3],
one wonders why he did not cite the other RCTs
that were performed with the same principle
and showed the efficacy and safety of ESWT in
muskuloskeletal disorders according to the
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distribution, and reproduction in any medium, pLevels I (evidence obtained from at least one
properly designed randomized controlled trial) and
II (evidence obtained from a well-designed cohort
or case-control analytic studies, preferably from
more than one center or research group) (EBM
levels established by the United States Preventive
Services Task Force; www.
uspreventiveservicestaskforce.org) [4-11].
 Wang’s [1] list of ESWT devices approved by the
United States Food and Drug Administration
(FDA) is incomplete. Actually, the following ESWT
devices obtained Premarket Approval (PMA) from
the FDA as Class III orthopedic lithotripsy devices
and were re-classified as Class III Generators,
Shock Wave, For Pain Relief (Product Code NBN)
in the spring 2009: (1) OssaTron (HealthTronics,
Inc., Marietta, GA, USA), PMA no. P990086
issued on October 12, 2000 to treat chronic heel
pain; (2) Epos Ultra (Dornier Medical Systems, Inc.,
Kennesaw, GA, USA), PMA no. P000048 issued on
January 15, 2002 for the treatment of chronic
plantar fasciitis for patients with symptoms of
plantar fasciitis for 6 months or more and a history
of unsuccessful conservative therapy; (3) SONOCUR
Basic (Siemens Medical Solutions, Inc., Iselin, NJ,
USA), PMA no. P010039 issued on July 19, 2002 for
the treatment of pain due to tennis elbow; (4)
Orthospec Extracorporeal Shock Wave Therapy
(Medispec, Ltd, Germantown, MD, USA), PMA no.
P040026 issued on April 1, 2005 for the treatment of
proximal plantar fasciitis with or without heel spur
in patients 18 years of age or older; (5) Orbasone
Pain Relief System (Orthometrix, Inc., White Plains,
NY, UAS), PMA no. P040039 issued on August 10,
2005 to relieve heel pain (proximal plantar fasciitis);
and (6) Swiss DolorClast (EMS Electro Medical
Systems; Dallas, TX, USA), PMA no. P050004 issued
on May 8, 2007 to treat heel pain associated with
chronic proximal plantar fasciitis.ntral Ltd. This is an Open Access article distributed under the terms of the
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rovided the original work is properly cited.
Császár and Schmitz Journal of Orthopaedic Surgery and Research 2013, 8:22 Page 2 of 2
http://www.josr-online.com/content/8/1/22The Swiss DolorClast is a device that makes use of the
ballistic/radial principle and was used in the studies men-
tioned above [2-11], including the studies by Gerdesmeyeret al. [2] and Rompe et al. [3] cited by Wang [1] as ESWT
studies. In summary, Wang’s [1] review appears incomplete
and should be revised.Author’s response
Ching-Jen Wang
In response to Dr. Christoph Schmitz and Nikolaus
Császár’s letter concerning my published article, the inclu-
sion of ballistic/radial principle shockwave as the fourth
shockwave technique remains controversial. Some consid-
ered the ballistic/radial shockwave as one form of shock-
wave technique even though the working mechanism may
be different from other shockwave devices. The articles
cited in an article is dependent on the time the article was
written, and they might not be complete as mentioned.
The lists of FDA-approved shockwave devices change
from time to time. The information in the article was pro-
vided based on the author’s best knowledge at that time,
and it is for reference only. I hope this response has an-
swered your questions satisfactorily. Thank you for the
interest in this article.
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